1. Home
  2. ATAI vs EIM Comparison

ATAI vs EIM Comparison

Compare ATAI & EIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • EIM
  • Stock Information
  • Founded
  • ATAI 2018
  • EIM 2002
  • Country
  • ATAI Germany
  • EIM United States
  • Employees
  • ATAI N/A
  • EIM N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • EIM Finance/Investors Services
  • Sector
  • ATAI Health Care
  • EIM Finance
  • Exchange
  • ATAI Nasdaq
  • EIM Nasdaq
  • Market Cap
  • ATAI 444.7M
  • EIM 522.9M
  • IPO Year
  • ATAI 2021
  • EIM N/A
  • Fundamental
  • Price
  • ATAI $3.76
  • EIM $9.55
  • Analyst Decision
  • ATAI Strong Buy
  • EIM
  • Analyst Count
  • ATAI 3
  • EIM 0
  • Target Price
  • ATAI $13.33
  • EIM N/A
  • AVG Volume (30 Days)
  • ATAI 6.6M
  • EIM 215.2K
  • Earning Date
  • ATAI 08-12-2025
  • EIM 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • EIM 4.32%
  • EPS Growth
  • ATAI N/A
  • EIM N/A
  • EPS
  • ATAI N/A
  • EIM N/A
  • Revenue
  • ATAI $1,863,000.00
  • EIM N/A
  • Revenue This Year
  • ATAI $423.05
  • EIM N/A
  • Revenue Next Year
  • ATAI N/A
  • EIM N/A
  • P/E Ratio
  • ATAI N/A
  • EIM N/A
  • Revenue Growth
  • ATAI 572.56
  • EIM N/A
  • 52 Week Low
  • ATAI $1.03
  • EIM $8.61
  • 52 Week High
  • ATAI $4.00
  • EIM $10.51
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 69.83
  • EIM 51.31
  • Support Level
  • ATAI $3.06
  • EIM $9.49
  • Resistance Level
  • ATAI $3.70
  • EIM $9.60
  • Average True Range (ATR)
  • ATAI 0.28
  • EIM 0.06
  • MACD
  • ATAI 0.03
  • EIM 0.01
  • Stochastic Oscillator
  • ATAI 89.08
  • EIM 63.64

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About EIM Eaton Vance Municipal Bond

Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.

Share on Social Networks: